What moved DNAX stock higher today?

DNAX stock moved higher due to a low prior close and concentrated buying, producing a large percentage change; volume was **1,310,000.00**, below the 50-day average, suggesting limited liquidity behind the move.

What is Meyka AI’s rating for DNAX stock?

Meyka AI rates DNAX with a score of **64.39** out of 100 (Grade B — HOLD). The grade factors S&P 500 and sector comparisons, financial growth, key metrics and analyst consensus.

Are there price targets or forecasts for DNAX stock?

There is no consensus price target. Meyka AI's forecast model projects **$0.0000** as a baseline; a speculative upside scenario to **$0.0010** would imply **900.00%**, but this is highly uncertain and not a guarantee.

What are the main risks for DNAX stock investors?

Main risks include ultra-low price per share, thin liquidity, negative book value, a small reported workforce, and limited transparency on revenues and audited results; these factors increase volatility and dilution risk.

US Stocks

DNAX stock jumps to $0.0001 on 09 Feb 2026 (PNK): liquidity and valuation in focus

ByHuzaifa Zahoor February 9, 2026February 9, 2026

DNAX stock is trading at $0.0001 on 09 Feb 2026 during U.S. market hours on the PNK exchange after a sharp move from the prior close of $0.0000. The trade on low-priced shares pushed volume to 1,310,000.00 against a 50-day average of 3,106,873.00, making DNAX one of today’s top gainers by percentage. We review price action, fundamentals, technicals, risks and what Meyka AI’s model and grade say about the outlook for DNA Brands, Inc. (DNAX) in the United States market.